Regis Technologies
Matthew Forster is a Senior Research Scientist in Process Chemistry at Regis Technologies since August 2022, previously serving as a Process Development Chemist at BoroPharm Inc. from June 2014 to July 2022, focusing on the development and optimization of chemical manufacturing processes for API intermediates. Matthew's earlier experience includes roles as an Assistant Chemist, where directed experiments were conducted to enhance process efficiency, and as an Undergraduate Research Assistant at the University of Michigan, synthesizing porphyrin compounds and gaining expertise in organic chemistry and analytical methods. Matthew holds a Bachelor of Science in Biochemistry from the University of Michigan, completed in 2014.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.